ARCT

Arcturus Therapeutics Holdings Inc (ARCT)

US
$ 12.85.35%

Price Chart

Key Statistics

Market Cap
$ 347.41M
P/E Ratio
0.00
Revenue (TTM)
$ 143.68M
Volume
349.42K
52W High
$ 45.00
52W Low
$ 8.04
Dividend Yield
0.00%
Beta
2.29

Technicals

50-Day MA
11.4992
200-Day MA
16.6898
52 Week High
45
52 Week Low
8.04

About ARCT

Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Employees
174
Headquarters
San Diego, CA
CEO
Mr. Joseph E. Payne M.Sc.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg